April 23, 2026: More Progress Made for Ozempic Blindness Lawsuits Despite being a relatively new litigation, the Ozempic blindness lawsuits are advancing quickly
Gastrointestinal side effectsincluding nausea, vomiting, and changes in food preferencescan further limit food choices and reduce protein consumption
The shortage rule To understand why compounding pharmacists can make copies of semaglutide (the key ingredient in Ozempic and Wegovy) and tirzepatide (the key ingredient in Mounjaro and Zepbound), you have to understand the shortage rule
The goal is protein-forward snacking rather than keto fat bombs, which tend to displace protein calories
Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and weight management
Therefore, we focused on the effect of semaglutide, a long-acting GLP1R agonist, on cardiac hypertrophy induced by pressure overload in this study